Abstract
Recent studies have revealed that human sodium taurocholate cotransporting polypeptide (SLC10A1 or NTCP) is a functional cellular receptor for hepatitis B virus (HBV). However, whether human NTCP can support HBV infection in mouse hepatocyte cell lines has not been clarified. Because an HBV-permissible mouse model would be helpful for the study of HBV pathogenesis, it is necessary to investigate whether human NTCP supports the susceptibility of mouse hepatocyte cell lines to HBV. The results show that exogenous human NTCP expression can render non-susceptible HepG2 (human), Huh7 (human), Hepa1–6 (mouse), AML-12 (mouse) cell lines and primary mouse hepatocyte (PMH) cells susceptible to hepatitis D virus (HDV) which employs HBV envelope proteins. However, human NTCP could only introduce HBV susceptibility in human-derived HepG2 and Huh7 cells, but not in mouse-derived Hepa1–6, AML-12 or PMH cells. These data suggest that although human NTCP is a functional receptor that mediates HBV infection in human cells, it cannot support HBV infection in mouse hepatocytes. Our study indicated that the restriction of HBV in mouse hepatocytes likely occurs after viral entry but prior to viral transcription. We have excluded the role of mouse hepatocyte nuclear factors in the restriction of the HBV life cycle and showed that knockdown or inhibition of Sting, TBK1, IRF3 or IRF7, the components of the anti-viral signaling pathways, had no effect on HBV infection in mouse hepatocytes. Therefore, murine restriction factors that limit HBV infection need to be identified before a HBV-permissible mouse line can be created.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH . Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 1984; 52: 396–402.
Ott JJ, Stevens GA, Groeger J, Wiersma ST . Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212–2219.
Hughes SA, Wedemeyer H, Harrison PM . Hepatitis delta virus. Lancet 2011; 378: 73–85.
Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C . Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995; 213: 292–299.
Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P . Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol 1999; 73: 2052–2057.
Chouteau P, Le Seyec J, Cannie I, Nassal M, Guguen-Guillouzo C, Gripon P . A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol 2001; 75: 11565–11572.
Blanchet M, Sureau C . Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 2007; 81: 5841–5849.
Le Duff Y, Blanchet M, Sureau C . The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol 2009; 83: 12443–12451.
Abou-Jaoude G, Sureau C . Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J Virol 2007; 81: 13057–13066.
Schulze A, Gripon P, Urban S . Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 2007; 46: 1759–1768.
Leistner CM, Gruen-Bernhard S, Glebe D . Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008; 10: 122–133.
Salisse J, Sureau C . A function essential to viral entry underlies the hepatitis B virus “a” determinant. J Virol 2009; 83: 9321–9328.
Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1: e00049.
Meier A, Mehrle S, Weiss TS, Mier W, Urban S . Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 2013; 58: 31–42.
Schieck A, Schulze A, Gahler C, Muller T, Haberkorn U, Alexandrov A et al. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology 2013; 58: 43–53.
Yan H, Peng B, He W, Zhong G, Qi Y, Ren B et al. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol 2013; 87: 7977–7991.
Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 1997; 41: 1715–1720.
Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 2012; 57: 720–729.
Yuan Q, Ge S, Xiong J, Yan Q, Li Z, Hao X et al. A novel immunoassay for PreS1 and/or core-related antigens for detection of HBsAg variants. J Virol Methods 2010; 168: 108–113.
Tang H, McLachlan A . Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc Natl Acad Sci USA 2001; 98: 1841–1846.
Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 2013; 501: 237–241.
Meier PJ, Stieger B . Bile salt transporters. Annu Rev Physiol 2002; 64: 635–661.
Alrefai WA, Gill RK . Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 2007; 24: 1803–1823.
Shiao T, Iwahashi M, Fortune J, Quattrochi L, Bowman S, Wick M et al. Structural and functional characterization of liver cell-specific activity of the human sodium/taurocholate cotransporter. Genomics 2000; 69: 203–213.
Jung D, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA . Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene. Am J Physiol Gastrointest Liver Physiol 2004; 286: G752–G761.
Seeger C, Mason WS . Sodium-dependent taurocholic cotransporting polypeptide: a candidate receptor for human hepatitis B virus. Gut 2013; 62: 1093–1095.
Guidotti LG, Matzke B, Schaller H, Chisari FV . High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158–6169.
Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, Yaniv M et al. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 2001; 75: 2900–2911.
Acknowledgements
This work was supported by National Scientific and Technological Major Project (2013ZX10002-002). We would like to thank Junzong Shao for editing our manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, H., Zhuang, Q., Wang, Y. et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol 11, 175–183 (2014). https://doi.org/10.1038/cmi.2013.66
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2013.66
Keywords
This article is cited by
-
Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis
Scientific Reports (2023)
-
SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA
Cellular & Molecular Immunology (2021)
-
Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections
Molecular Imaging and Biology (2020)
-
HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models
BMC Cancer (2019)
-
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Nature Reviews Gastroenterology & Hepatology (2016)